Triazinoindole-based chemical inhibitors of eukaryotic ribosome genesis are disclosed. The compounds have the following structure: The compounds disclosed are useful in treatment of fungal disease and similar diseases associated with the dysregulation of the midasin signaling pathway.
本发明揭示了基于三嗪
吲哚的
化学抑制剂,可抑制真核
生物核糖体的生成。所述化合物具有以下结构:所述化合物可用于治疗真菌病和与midasin信号通路失调相关的类似疾病。